401 related articles for article (PubMed ID: 25423492)
1. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo.
Tapia-Rojas C; Schüller A; Lindsay CB; Ureta RC; Mejías-Reyes C; Hancke J; Melo F; Inestrosa NC
Biochem J; 2015 Mar; 466(2):415-30. PubMed ID: 25423492
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide Stimulates Neurogenesis in the Adult Hippocampus.
Varela-Nallar L; Arredondo SB; Tapia-Rojas C; Hancke J; Inestrosa NC
Neural Plast; 2015; 2015():935403. PubMed ID: 26798521
[TBL] [Abstract][Full Text] [Related]
3. Polycyclic aromatic hydrocarbons and dibutyl phthalate disrupt dorsal-ventral axis determination via the Wnt/β-catenin signaling pathway in zebrafish embryos.
Fairbairn EA; Bonthius J; Cherr GN
Aquat Toxicol; 2012 Nov; 124-125():188-96. PubMed ID: 22975441
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.
Bergmann C; Akhmetshina A; Dees C; Palumbo K; Zerr P; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2011 Dec; 70(12):2191-8. PubMed ID: 21873331
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway.
Yue H; Lu F; Shen C; Quan JM
Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861
[TBL] [Abstract][Full Text] [Related]
7. Wnt3a ligand facilitates autophagy in hippocampal neurons by modulating a novel GSK-3β-AMPK axis.
Ríos JA; Godoy JA; Inestrosa NC
Cell Commun Signal; 2018 Apr; 16(1):15. PubMed ID: 29642895
[TBL] [Abstract][Full Text] [Related]
8. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling.
Briolotti P; Chaloin L; Balaguer P; Da Silva F; Tománková V; Pascussi JM; Duret C; Fabre JM; Ramos J; Klieber S; Maurel P; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Sci; 2015 Nov; 148(1):261-75. PubMed ID: 26259606
[TBL] [Abstract][Full Text] [Related]
10. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
[TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-TCDD induces neurotoxicity and neuronal apoptosis in the rat brain cortex and PC12 cell line through the down-regulation of the Wnt/β-catenin signaling pathway.
Xu G; Zhou Q; Wan C; Wang Y; Liu J; Li Y; Nie X; Cheng C; Chen G
Neurotoxicology; 2013 Jul; 37():63-73. PubMed ID: 23619006
[TBL] [Abstract][Full Text] [Related]
12. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner.
Caspi M; Zilberberg A; Eldar-Finkelman H; Rosin-Arbesfeld R
Oncogene; 2008 Jun; 27(25):3546-55. PubMed ID: 18223684
[TBL] [Abstract][Full Text] [Related]
13. A new protocol for predicting novel GSK-3β ATP competitive inhibitors.
Fang J; Huang D; Zhao W; Ge H; Luo HB; Xu J
J Chem Inf Model; 2011 Jun; 51(6):1431-8. PubMed ID: 21615159
[TBL] [Abstract][Full Text] [Related]
14. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity.
Arfeen M; Patel R; Khan T; Bharatam PV
J Biomol Struct Dyn; 2015; 33(12):2578-93. PubMed ID: 26209183
[TBL] [Abstract][Full Text] [Related]
16. Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin.
Ren X; Rizavi HS; Khan MA; Dwivedi Y; Pandey GN
Int J Neuropsychopharmacol; 2013 Jun; 16(5):945-55. PubMed ID: 23110823
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.
Garrido JL; Godoy JA; Alvarez A; Bronfman M; Inestrosa NC
FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
20. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]